NCT03838640View on ClinicalTrials.gov

Feasibility of Transnasal ECHO for Identification of Parapharyngeal Internal Carotid Artery

NACompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

August 5, 2019

Primary Completion Date

May 1, 2022

Study Completion Date

May 1, 2022

Conditions
To Assess Feasibility of the New Application
Interventions
DEVICE

EPIQ 5

As described in summary Trade name of the device Philips EPIQ 5

Trial Locations (1)

52621

Sheba Medical Center, Tel Litwinsky

All Listed Sponsors
lead

Sheba Medical Center

OTHER_GOV

NCT03838640 - Feasibility of Transnasal ECHO for Identification of Parapharyngeal Internal Carotid Artery | Biotech Hunter | Biotech Hunter